{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T20:43:18Z","timestamp":1793133798317,"version":"4.5.0"},"reference-count":29,"publisher":"SAGE Publications","issue":"5","license":[{"start":{"date-parts":[[2018,6,22]],"date-time":"2018-06-22T00:00:00Z","timestamp":1529625600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["J Oncol Pharm Pract"],"published-print":{"date-parts":[[2019,7]]},"abstract":"<jats:p>Azacitidine, a deoxyribonucleic acid hypomethylating agent, is used in the treatment of myelodysplastic syndrome. Common adverse effects of azacitidine include bone marrow suppression, injection site reactions, nausea, vomiting, diarrhea, and fatigue. This report focuses on pleuropericardial effusions, an infrequently reported and potentially reversible adverse effect of azacitidine. In this case report, pleuropericardial effusion manifested as the sole radiographic finding in the evaluation of cough occurring during the eighth cycle of treatment with azacitidine. Symptoms and radiographic abnormalities resolved with corticosteroids and diuretics, and the patient could continue with therapy.<\/jats:p>","DOI":"10.1177\/1078155218784762","type":"journal-article","created":{"date-parts":[[2018,6,23]],"date-time":"2018-06-23T02:08:29Z","timestamp":1529719709000},"page":"1248-1252","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":9,"title":["Azacitidine-associated pleuropericardial effusion in myelodysplastic syndrome: A case report"],"prefix":"10.1177","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9199-2989","authenticated-orcid":false,"given":"Kelli","family":"Goo","sequence":"first","affiliation":[{"name":"The Daniel K. Inouye College of Pharmacy, University of Hawai`i at Hilo, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosalynda","family":"Uy","sequence":"additional","affiliation":[{"name":"Tripler Army Medical Center, Honolulu, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Roswarski","sequence":"additional","affiliation":[{"name":"Tripler Army Medical Center, Honolulu, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2018,6,22]]},"reference":[{"key":"bibr1-1078155218784762","unstructured":"American Cancer Society. What are myelodysplastic syndromes? www.cancer.org\/cancer\/myelodysplastic-syndrome\/about\/what-is-mds.html (2015, accessed 8 December 2017)."},{"key":"bibr2-1078155218784762","doi-asserted-by":"crossref","first-page":"7121","DOI":"10.1182\/blood-2011-02-337964","volume":"117","author":"Cogle CR","year":"2011","journal-title":"Blood"},{"key":"bibr3-1078155218784762","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/BF02994001","volume":"73","author":"Aul C","year":"2001","journal-title":"Int J Hematol"},{"key":"bibr4-1078155218784762","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1016\/j.amjmed.2012.04.014","volume":"125","author":"Ma X","year":"2012","journal-title":"Am J Med"},{"key":"bibr5-1078155218784762","unstructured":"American Cancer Society. What are the key statistics about myelodysplastic syndromes? www.cancer.org\/cancer\/myelodysplastic-syndrome\/about\/key-statistics.html (2015, accessed 8 December 2017)."},{"key":"bibr6-1078155218784762","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2012-03-420489"},{"key":"bibr7-1078155218784762","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(09)70003-8"},{"key":"bibr8-1078155218784762","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2002.04.117"},{"key":"bibr9-1078155218784762","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1205699"},{"key":"bibr10-1078155218784762","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2012-0465"},{"key":"bibr11-1078155218784762","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.23607"},{"key":"bibr12-1078155218784762","unstructured":"Celgene Corporation. Vidaza (package insert). Summit, NJ: Celgene Corporation, 2016."},{"key":"bibr13-1078155218784762","unstructured":"U.S. Food and Drug Administration. FDA adverse events reporting system (FAERS) public dashboard, https:\/\/fis.fda.gov\/sense\/app\/777e9f4d-0cf8-448e-8068-f564c31baa25\/sheet\/45beeb74-30ab-46be-8267-5756582633b4\/state\/analysis (2018, accessed 20 May 2018)."},{"key":"bibr14-1078155218784762","doi-asserted-by":"crossref","first-page":"S95","DOI":"10.1016\/S0145-2126(15)30191-0","volume":"39","author":"Ganipisetti V","year":"2015","journal-title":"Leuk Res"},{"key":"bibr15-1078155218784762","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1111\/ejh.12598","volume":"95","author":"Laufer CB","year":"2005","journal-title":"Eur J Haematol"},{"key":"bibr16-1078155218784762","first-page":"4","volume":"4","author":"Misra SC","year":"2017","journal-title":"Drug Saf"},{"key":"bibr17-1078155218784762","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra0902908"},{"key":"bibr18-1078155218784762","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra072067"},{"key":"bibr19-1078155218784762","doi-asserted-by":"crossref","first-page":"111","DOI":"10.4082\/kjfm.2014.35.3.111","volume":"35","author":"Samiev D","year":"2014","journal-title":"Korean J Fam Med"},{"key":"bibr20-1078155218784762","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.25774"},{"key":"bibr21-1078155218784762","doi-asserted-by":"crossref","first-page":"44","DOI":"10.3747\/co.21.1871","volume":"21","author":"Wells RA","year":"2014","journal-title":"Curr Oncol"},{"key":"bibr22-1078155218784762","doi-asserted-by":"publisher","DOI":"10.1111\/ejh.12079"},{"key":"bibr23-1078155218784762","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1002\/cncr.24946","volume":"116","author":"Sampat K","year":"2010","journal-title":"Cancer"},{"key":"bibr24-1078155218784762","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1093\/eurheartj\/ehs372","volume":"34","author":"Imazo M","year":"2013","journal-title":"Eur Heart J"},{"key":"bibr25-1078155218784762","doi-asserted-by":"publisher","DOI":"10.2147\/OAEM.S29942"},{"key":"bibr26-1078155218784762","doi-asserted-by":"publisher","DOI":"10.4330\/wjc.v3.i5.135"},{"key":"bibr27-1078155218784762","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1002\/phar.1733","volume":"36","author":"Newman M","year":"2016","journal-title":"Pharmacotherapy"},{"key":"bibr28-1078155218784762","doi-asserted-by":"crossref","first-page":"e150","DOI":"10.1016\/j.leukres.2008.11.028","volume":"33","author":"Chen CC","year":"2009","journal-title":"Leuk Res"},{"key":"bibr29-1078155218784762","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1981.154"}],"container-title":["Journal of Oncology Pharmacy Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/1078155218784762","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/1078155218784762","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/1078155218784762","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T02:18:59Z","timestamp":1777688339000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/1078155218784762"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,22]]},"references-count":29,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,7]]}},"alternative-id":["10.1177\/1078155218784762"],"URL":"https:\/\/doi.org\/10.1177\/1078155218784762","relation":{},"ISSN":["1078-1552","1477-092X"],"issn-type":[{"value":"1078-1552","type":"print"},{"value":"1477-092X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,6,22]]}}}